Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 01, 2015 5:32 PM ET

Leisure Products

Company Overview of X2 Biosystems, Inc.

Company Overview

X2 Biosystems, Inc. develops systems for the management of sport brain injury. It offers head impact monitoring systems for helmeted and non-helmeted sports. The company provides custom fitted or boil-and-bite protective mouth-guards for helmeted sports; and low profile adhesive patches for non-helmeted sports that hold sensor pods behind athlete’s ear. Its products are used in men’s and women’s contact, gravity, and motor sports; by football, soccer, hockey, and lacrosse athletes; and in more sports and military uses. The company was founded in 2010 and is based in Seattle, Washington.

1927 Post Alley

Suite 200

Seattle, WA 98101

United States

Founded in 2010

Key Executives for X2 Biosystems, Inc.

Chief Executive Officer
Founder and Chief Marketing Officer
Vice President of Finance and Operations
President of Government & Industrial Division and Chairman of Military Advisory Board
Chief of Clinical Affairs
Compensation as of Fiscal Year 2015.

X2 Biosystems, Inc. Key Developments

The National Hockey League Adopts X2 Biosystems' Concussion Evaluation and Management Software

X2 Biosystems entered into an agreement with the National Hockey League to supply its Integrated Concussion Evaluation software application for use by all 30 NHL teams during the 2014-15 season. The X2 Biosystems ICE is a cloud-based concussion examination and data management system that integrates both baseline and post-injury player assessments, and includes iOS and Windows tablet applications for touch screen data input and retrieval. Equally suitable for evaluation of the player at the rink or in clinical office settings, ICE provides authorized team health care providers with secure access to and analysis of their players' historical and current examination information. The X2 Biosystems ICE enables practitioners to document early warning signs of concussions and traumatic brain injury, making it an important contribution to enhancing player safety.

U.S. Army Medical Research and Materiel Command Awards Contract to X2 Biosystems and Trifecta Solutions LLC

X2 Biosystems and Trifecta Solutions LLC have been awarded a contract from the U.S. Army Medical Research and Materiel Command facilitating the Army's evaluation of X2 Biosystems' world leading, comprehensive software and sensor suite for the detection and management of concussive and other traumatic brain injuries. The contract was awarded through the Rapid Innovation Fund (RIF) Program, which allows the Department of Defense (DoD) to fund programs that facilitate rapid adoption of innovative technologies into military systems and programs that meet critical national security needs and have a demonstration path into a defense acquisition program. The award underscores the Army's focus on addressing traumatic brain injury (TBI) because it continues to be a significant issue for service men and women due to injuries that occur during training and military operations. The Army has noted that combat medics need to be able to accurately and objectively assess soldiers with mild to moderate TBI up to 24 hours post injury, improving diagnosis, treatment, rehabilitation, and return to duty. Ultimately, the Army's goal is to ensure more rapid and appropriate treatment of service people to improve short and long term outcomes of mild and moderate TBI.

X2 Biosystems, Inc. Appoints Major General Stephen Layfield as President of the Company's Government and Industrial Division

X2 Biosystems announced the appointment of Major General Stephen Layfield as President of the company's Government and Industrial Division. Major General Layfield (Ret.) will play a key role in advancing the company's growth and profitability within the Government and Industrial Division. Major General Layfield is a proven military leader and a highly accomplished strategic planner. His depth of knowledge and experience will be a true asset in driving adoption of X2 Biosystems' technology within the military and industrial communities. Major General Layfield (Ret.) brings more than 30 years of senior leadership, training, and command experience to his position. In addition to his multiple operational deployments, Major General Layfield (Ret.) has managed the training and development of diverse American and multi-national organizations of up to 42,000 personnel.

Similar Private Companies By Industry

Company Name Region
Point One Racing, LLC United States
Zelosport LLC United States
American Eagle Motorcycle United States
Schutt Holdings, Inc. United States
Discovery Toys, L.L.C. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 2, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact X2 Biosystems, Inc., please visit www.x2biosystems.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.